132 related articles for article (PubMed ID: 1737378)
21. Cytostatic and cytotoxic action of Z-1, 1-dichloro-2,3-diphenylcyclopropane in three human breast cancer cell lines.
ter Haar E; Day BW
Anticancer Res; 1996; 16(3A):1107-15. PubMed ID: 8702221
[TBL] [Abstract][Full Text] [Related]
22. Differential regulation of expression of three transforming growth factor beta species in human breast cancer cell lines by estradiol.
Arrick BA; Korc M; Derynck R
Cancer Res; 1990 Jan; 50(2):299-303. PubMed ID: 2295070
[TBL] [Abstract][Full Text] [Related]
23. Interleukin 4 inhibits growth and induces apoptosis in human breast cancer cells.
Gooch JL; Lee AV; Yee D
Cancer Res; 1998 Sep; 58(18):4199-205. PubMed ID: 9751635
[TBL] [Abstract][Full Text] [Related]
24. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.
Ciardiello F; McGeady ML; Kim N; Basolo F; Hynes N; Langton BC; Yokozaki H; Saeki T; Elliott JW; Masui H
Cell Growth Differ; 1990 Sep; 1(9):407-20. PubMed ID: 1981145
[TBL] [Abstract][Full Text] [Related]
25. A phase II multi-institutional study of estra-1,3,5(10)-triene-3,17 beta-diol, 3-benzoate, 17[[4-[4-[bis(2-chloroethyl)amino]phenyl]-1- oxobutoxy]acetate] (KM2210), a novel antitumor agent, for advanced and recurrent breast carcinoma.
Kubota T; Abe O; Izuo M; Watanabe H; Enomoto K; Ohsawa N; Kuno K
Anticancer Res; 1993; 13(6B):2361-5. PubMed ID: 8135468
[TBL] [Abstract][Full Text] [Related]
26. Osteoblast-derived growth factors enhance adriamycin-cytostasis of MCF-7 human breast cancer cells.
Choki I; Sourla A; Reyes-Moreno C; Koutsilieris M
Anticancer Res; 1998; 18(6A):4213-24. PubMed ID: 9891470
[TBL] [Abstract][Full Text] [Related]
27. Effect of alpha-interferon, 17 beta-estradiol, and tamoxifen on estrogen receptor concentration and cell cycle kinetics of MCF 7 cells.
Bezwoda WR; Meyer K
Cancer Res; 1990 Sep; 50(17):5387-91. PubMed ID: 2386944
[TBL] [Abstract][Full Text] [Related]
28. Tumor necrosis factor alpha enhances secretion of transforming growth factor beta2 in MCF-7 breast cancer cells.
Danforth DN; Sgagias MK
Clin Cancer Res; 1996 May; 2(5):827-35. PubMed ID: 9816237
[TBL] [Abstract][Full Text] [Related]
29. Interleukin 1 alpha blocks estradiol-stimulated growth and down-regulates the estrogen receptor in MCF-7 breast cancer cells in vitro.
Danforth DN; Sgagias MK
Cancer Res; 1991 Mar; 51(5):1488-93. PubMed ID: 1997187
[TBL] [Abstract][Full Text] [Related]
30. The alloantigen-specific immunosuppressive activity of estradiol-chlorambucil conjugate (KM2210) and its beneficial effect on allogeneic bone marrow transplantation in mice.
Matsudaira T; Kodo H; Okamoto S; Tani K; Tojo A; Ozawa K; Asano K; Asano S
Transplantation; 1992 Oct; 54(4):676-81. PubMed ID: 1384190
[TBL] [Abstract][Full Text] [Related]
31. [Synthetic estrogens--new pharmacological actions and mechanisms].
Kosano H; Nishigori H
Nihon Rinsho; 1994 Mar; 52(3):587-92. PubMed ID: 8164354
[TBL] [Abstract][Full Text] [Related]
32. Blockade of the epidermal growth factor receptor inhibits transforming growth factor alpha-induced but not estrogen-induced growth of hormone-dependent human breast cancer.
Arteaga CL; Coronado E; Osborne CK
Mol Endocrinol; 1988 Nov; 2(11):1064-9. PubMed ID: 3221874
[TBL] [Abstract][Full Text] [Related]
33. Growth stimulation and differential regulation of transforming growth factor-beta 1 (TGF beta 1), TGF beta 2, and TGF beta 3 messenger RNA levels by norethindrone in MCF-7 human breast cancer cells.
Jeng MH; Jordan VC
Mol Endocrinol; 1991 Aug; 5(8):1120-8. PubMed ID: 1834933
[TBL] [Abstract][Full Text] [Related]
34. Effects of intra-arterial chemotherapy with a new lipophilic anticancer agent, estradiol-chlorambucil (KM2210), dissolved in lipiodol on experimental liver tumor in rats.
Egawa H; Maki A; Mori K; Yamamoto Y; Mitsuhashi S; Bannai K; Asano K; Ozawa K
J Surg Oncol; 1990 Jun; 44(2):109-14. PubMed ID: 2162452
[TBL] [Abstract][Full Text] [Related]
35. Effects of intraarterial chemotherapy using the new lipophilic anticancer agent 'KM2210' (estradiol-chlorambucil) dissolved in lipiodol on Walker 256 carcinosarcoma in Wistar rats--a preliminary report.
Egawa H; Mori K; Mitsuhashi S; Bannai K; Asano K; Ozawa K
Eur Surg Res; 1990; 22(4):219-23. PubMed ID: 2176158
[TBL] [Abstract][Full Text] [Related]
36. Dibenzo[a,g]quinolizin-8-ones: synthesis, estrogen receptor affinities, and cytostatic activity.
von Angerer S; Brandl G; Mannschreck A; Weimar C; Wiegrebe W
Anticancer Drug Des; 1992 Oct; 7(5):351-63. PubMed ID: 1388628
[TBL] [Abstract][Full Text] [Related]
37. Effect of prolactin on growth and the estrogen receptor level of human breast cancer cells (MCF-7).
Shafie S; Brooks SC
Cancer Res; 1977 Mar; 37(3):792-9. PubMed ID: 189915
[TBL] [Abstract][Full Text] [Related]
38. Proliferation kinetics of a human breast cancer line in vitro following treatment with 17beta-estradiol and 1-beta-D-arabinofuranosylcytosine.
Weichselbaum RR; Hellman S; Piro AJ; Nove JJ; Little JB
Cancer Res; 1978 Aug; 38(8):2339-42. PubMed ID: 667830
[TBL] [Abstract][Full Text] [Related]
39. Cytotoxic activity of G3 PAMAM-NH₂ dendrimer-chlorambucil conjugate in human breast cancer cells.
Bielawski K; Bielawska A; Muszyńska A; Popławska B; Czarnomysy R
Environ Toxicol Pharmacol; 2011 Nov; 32(3):364-72. PubMed ID: 22004955
[TBL] [Abstract][Full Text] [Related]
40. Alpha 1-antitrypsin blocks the release of transforming growth factor-alpha from MCF-7 human breast cancer cells.
Yavelow J; Tuccillo A; Kadner SS; Katz J; Finlay TH
J Clin Endocrinol Metab; 1997 Mar; 82(3):745-52. PubMed ID: 9062476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
